Tumor cells can induce drug resistance through inducing drug efflux pump (p-glycoprotein or MDR1), by up-regulation of anti-apoptotic genes (Bcl-2, Bcl-xl) or by other mechanisms [16]. Here, BCL2L1 is linked to neoplasm.